Intended for healthcare professionals

CCBYNC Open access
Research

Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis

BMJ 2022; 378 doi: https://doi.org/10.1136/bmj-2021-067606 (Published 02 August 2022) Cite this as: BMJ 2022;378:e067606